Fabian López-Vallejo

Prof. Fabian López-Vallejo

Universidad Nacional De Colombia Sede Manizales, Manizales, Caldas, Colombia
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2011 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SCSabrina Castellano
Sabrina Castellano
DKDirk Kuck
Dirk Kuck
MVMonica Viviano
Monica Viviano
JYJakyung Yoo
Jakyung Yoo
FLFabian López-Vallejo
Fabian López-Vallejo
GGianluca Sbardella
Gianluca Sbardella

1 July 2011 in Combinatorial Chemistry & High Throughput Screening
Verified
Journal Article
Closed access
PDF file
FLFabian López-Vallejo
Fabian López-Vallejo
Thomas CaulfieldThomas Caulfield
Thomas Caulfield
KMKarina Martinez-Mayorga
Karina Martinez-Mayorga
MGMarc A. Giulianotti
Marc A. Giulianotti
ANAdel Nefzi
Adel Nefzi
JMJose L. Medina-Franco
Jose L. Medina-Franco
Virtual screening is increasingly being used in drug discovery programs with a growing number of successful applications. Experimental methodologies developed to speed up the drug discovery processes include high throughput screening and combinatorial chemistry. The complementarities between computational and experimental screenings have been recognized and reviewed in the literature. Computational methods have also been used in the combinatorial chemistry field, in particular in library design. However, the integration of computational and combinatorial chemistry screenings has been attempted only recently. Combinatorial libraries (experimental or virtual) represent a notable source of chemically related compounds. Advances in combinatorial chemistry and deconvolution strategies, have enabled the rapid exploration of novel and dense regions in the chemical space. The present review is focused on the integration of virtual and experimental screening of combinatorial libraries. Applications of virtual screening to discover novel anticancer agents and our ongoing efforts towards the integration of virtual screening and combinatorial chemistry are also discussed.

10 August 2010 in Molecular Diversity
Verified
Journal Article
Closed access
PDF file
JMJose Medina-Franco
Jose Medina-Franco
FLFabian López-Vallejo
Fabian López-Vallejo
DKDirk Kuck
Dirk Kuck
FLFrank Lyko
Frank Lyko

1 July 2012 in Drug Discovery Today
Verified
Journal Article
Closed access
FLFabian López-Vallejo
Fabian López-Vallejo
MGMarc A. Giulianotti
Marc A. Giulianotti
RHRichard A. Houghten
Richard A. Houghten
JMJosé L. Medina-Franco
José L. Medina-Franco

1 June 2011 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JRJuan José Ramírez-Espinosa
Juan José Ramírez-Espinosa
Maria Yolanda RiosMaria Yolanda Rios
Maria Yolanda Rios
SLSugey Lopez-Martinez
Sugey Lopez-Martinez
FLFabian López-Vallejo
Fabian López-Vallejo
JMJosé L. Medina-Franco
José L. Medina-Franco
SESamuel Estrada-Soto
Samuel Estrada-Soto

8 July 2011 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
JOJohn R. Owen
John R. Owen
INIan T. Nabney
Ian T. Nabney
JMJosé L. Medina-Franco
José L. Medina-Franco
FLFabian López-Vallejo
Fabian López-Vallejo